BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Advanced Enzyme Technologies Ltd. has recently launched Covid-19 immunity management products after conducting clinical trials on 200 patients.
The bundle of ImmunoSEB and Biome Ultra is available only on Amazon and priced at Rs 2,490 (15 days pack).
The outcome of these clinical trials was the resolution of post-Covid-19 fatigue and reduced discharge time.
Advanced Enzyme’s management claims that it is the only clinically approved product in India, which deals with the post-Covid fatigue.
We believe that since this is an over-the-counter product (not a doctor prescribed product), marketing strategy is very critical.
The health supplements space is a crowded market on e-commerce platforms at attractive price points.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.